Science Explorer Back to mapMap
Discussion
Researcher · Kennedy Center · Denmark

Thomas Rosenberg

Thomas Rosenberg publishes mostly in Molecular Biology, Ophthalmology and Genetics, on topics such as Retinal Development and Disorders, Retinal Diseases and Treatments and Connexins and lens biology.

ORCID 0000-0003-0095-8991 OpenAlex
World rank
#721,211
of 7,710,434 ranked researchers
Rank in Denmark
#5,442
of 43,819
Works
278
Citations
12k
Citations per work
44.7
h-index
64
i10-index 169Top 1.6% in Molecular Biology
Thomas Rosenberg

What does Thomas Rosenberg research?

Thomas Rosenberg's work is mostly in Biochemistry, Genetics and Molecular Biology (44%), Medicine (23%).

Life Sciences: 121 works · 43.6% of their workBiochemistry, Genetics and Molecular Biology: 121 works · 43.6% of their workMolecular Biology: 88 works · 31.6% of their workGenetics: 25 works · 8.9% of their workCell Biology: 9 works · 3.1% of their workEverything else: 92 works · 33.1% of their workHealth Sciences: 65 works · 23.3% of their workMedicine: 65 works · 23.3% of their workOphthalmology: 35 works · 12.7% of their workRadiology, Nuclear Medicine and Imaging: 18 works · 6.4% of their workEpidemiology: 12 works · 4.2% of their workTHEIR WORKThomas Rosenberg278works
Life Sciences44%Health Sciences23%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology12143.6%
  2. Everything else9233.1%
    1. Medicine6523.3%
  1. 1Molecular Biology32% of their works
  2. 2Ophthalmology13% of their works
  3. 3Genetics9% of their works
  4. 4Radiology, Nuclear Medicine and Imaging6% of their works
  5. 5Epidemiology4% of their works
  6. 6Cell Biology3% of their works

Research topics

Which keywords describe Thomas Rosenberg's research?

The keywords of their largest research topics: Macular Degeneration, Gene Therapy, Retinitis Pigmentosa, Oxidative Stress, Vascular Endothelial Growth Factor, Diabetic Retinopathy, Retinal Pigment Epithelium and Connexins.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Macular Degeneration1272 topics
  2. Gene Therapy881 topic
  3. Retinitis Pigmentosa881 topic
  4. Oxidative Stress602 topics
  5. Vascular Endothelial Growth Factor602 topics
  6. Diabetic Retinopathy391 topic
  7. Retinal Pigment Epithelium391 topic
  8. Connexins291 topic
  9. Gap Junctions291 topic
  10. Myopia261 topic
  11. Visual Impairment261 topic
  12. Glaucoma231 topic
  13. Intraocular Pressure231 topic
  14. Mitochondria211 topic
  15. Prematurity211 topic
  16. Reactive Oxygen Species211 topic
  17. Retinopathy211 topic
  18. Microphthalmia191 topic
  19. Ocular Development191 topic

Where does Thomas Rosenberg work?

Thomas Rosenberg's main affiliation in the publication record is Kennedy Center, Denmark.

How many publications and citations does Thomas Rosenberg have?

OpenAlex counts 278 works and 12,416 citations for Thomas Rosenberg, an h-index of 64, ranking #721,211 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Thomas Rosenberg. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.